KISS1 and depressive symptom measurement: Thus, it does not appear that the concentrations of SPX, PNX, nesfatin-1 or kisspeptin can be used as biomarkers for the severity of BD in the way that Sun et al. considered nesfatin-1 in depression in their 2023 study [23].